The Treatment of Heart Failure in Patients with Chronic Kidney Disease: Doubts and New Developments from the Last ESC Guidelines

Patients with heart failure (HF) and associated chronic kidney disease (CKD) are a population less represented in clinical trials; additionally, subjects with more severe estimated glomerular filtration rate reduction are often excluded from large studies. In this setting, most of the data come from...

Descripción completa

Detalles Bibliográficos
Autores principales: Beltrami, Matteo, Milli, Massimo, Dei, Lorenzo Lupo, Palazzuoli, Alberto
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9025648/
https://www.ncbi.nlm.nih.gov/pubmed/35456336
http://dx.doi.org/10.3390/jcm11082243

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9025648/
https://www.ncbi.nlm.nih.gov/pubmed/35456336
http://dx.doi.org/10.3390/jcm11082243

Ejemplares similares